Marshall L. Mohr's most recent trade in Veeva Systems Inc - Ordinary Shares - Class A was a trade of 1,155 Restricted Stock Units done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 1,155 | 1,155 | - | - | Restricted Stock Units | |
| Pacific Biosciences of Cal... | Marshall L. Mohr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 385 | 4,821 (0%) | 0% | 0 | Class A Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 385 | 0 | - | - | Restricted Stock Units | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 384 | 4,436 (0%) | 0% | 0 | Class A Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 384 | 385 | - | - | Restricted Stock Units | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 385 | 769 | - | - | Restricted Stock Units | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 385 | 4,052 (0%) | 0% | 0 | Class A Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 385 | 1,154 | - | - | Restricted Stock Units | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 385 | 3,667 (0%) | 0% | 0 | Class A Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 31 Aug 2024 | 3,348 | 3,348 (0%) | 0% | 0 | Common Stock | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 31 Aug 2024 | 1,698 | 1,650 (0%) | 0% | 492.6 | 836,486 | Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 1,539 | 1,539 | - | - | Restricted Stock Units | |
| Pacific Biosciences of Cal... | Marshall L. Mohr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 32,179 | 32,179 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Marshall L. Mohr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 22,821 | 132,821 (0%) | 0% | 0 | Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 339 | 3,282 (0%) | 0% | 0 | Class A Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 339 | 0 | - | - | Restricted Stock Units | |
| Pacific Biosciences of Cal... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.45 per share. | 01 Mar 2024 | 25,000 | 110,000 (0%) | 0% | 4.5 | 111,250 | Common Stock |
| Pacific Biosciences of Cal... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 339 | 339 | - | - | Restricted Stock Units | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 339 | 2,943 (0%) | 0% | 0 | Class A Common Stock | |
| Intuitive Surgical | L. Marshall Mohr | Executive VP Global Business S | 28 Feb 2024 | 22,500 | 57,257 (0%) | 0% | 79.6 | 1,791,851 | Common Stock | |
| Intuitive Surgical | L. Marshall Mohr | Executive VP Global Business S | 28 Feb 2024 | 22,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Intuitive Surgical | L. Marshall Mohr | Executive VP Global Business S | 28 Feb 2024 | 22,500 | 49,377 (0%) | 0% | 109.5 | 2,463,426 | Common Stock | |
| Intuitive Surgical | L. Marshall Mohr | Executive VP Global Business S | 28 Feb 2024 | 22,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Intuitive Surgical | L. Mohr Marshall | Executive VP Global Business S | 28 Feb 2024 | 14,620 | 34,757 (0%) | 0% | 385.1 | 5,630,044 | Common Stock | |
| Intuitive Surgical | L. Marshall Mohr | Executive VP Global Business S | 28 Feb 2024 | 13,750 | 43,507 (0%) | 0% | 385.1 | 5,294,842 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2024 | 13,530 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Intuitive Surgical | Marshall Mohr L. | Executive VP Global Business S | 28 Feb 2024 | 13,530 | 40,407 (0%) | 0% | 178.0 | 2,408,160 | Common Stock | |
| Intuitive Surgical | Mohr Marshall L. | Executive VP Global Business S | 28 Feb 2024 | 13,530 | 40,407 (0%) | 0% | 242.3 | 3,278,816 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2024 | 13,530 | 26,877 (0%) | 0% | 385.1 | 5,210,139 | Common Stock | |
| Intuitive Surgical | Mohr L. Marshall | Executive VP Global Business S | 28 Feb 2024 | 13,530 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Intuitive Surgical | L. Mohr Marshall | Executive VP Global Business S | 28 Feb 2024 | 13,530 | 26,877 (0%) | 0% | 385.1 | 5,210,139 | Common Stock | |
| Intuitive Surgical | L. Mohr Marshall | Executive VP Global Business S | 28 Feb 2024 | 12,750 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Intuitive Surgical | Marshall Mohr L. | Executive VP Global Business S | 28 Feb 2024 | 12,750 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Intuitive Surgical | Mohr Marshall L. | Executive VP Global Business S | 28 Feb 2024 | 12,750 | 26,877 (0%) | 0% | 385.1 | 4,909,776 | Common Stock | |
| Intuitive Surgical | Mohr Marshall L. | Executive VP Global Business S | 28 Feb 2024 | 12,750 | 26,877 (0%) | 0% | 385.1 | 4,909,776 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2024 | 12,750 | 39,627 (0%) | 0% | 174.3 | 2,221,773 | Common Stock | |
| Intuitive Surgical | Mohr Marshall L. | Executive VP Global Business S | 28 Feb 2024 | 12,750 | 39,627 (0%) | 0% | 139.5 | 1,778,880 | Common Stock | |
| Intuitive Surgical | L. Marshall Mohr | Executive VP Global Business S | 28 Feb 2024 | 11,250 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Intuitive Surgical | L. Marshall Mohr | Executive VP Global Business S | 28 Feb 2024 | 11,250 | 54,757 (0%) | 0% | 77.0 | 866,238 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2024 | 10,500 | 37,377 (0%) | 0% | 166.6 | 1,749,545 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2024 | 10,500 | 26,877 (0%) | 0% | 385.1 | 4,043,345 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2024 | 10,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2024 | 10,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2024 | 10,500 | 47,897 (0%) | 0% | 385.1 | 4,043,345 | Common Stock | |
| Intuitive Surgical | Mohr Marshall L. | Executive VP Global Business S | 28 Feb 2024 | 10,500 | 58,397 (0%) | 0% | 182.8 | 1,919,750 | Common Stock | |
| Intuitive Surgical | L. Marshall Mohr | Executive VP Global Business S | 28 Feb 2024 | 6,860 | 47,897 (0%) | 0% | 385.1 | 2,641,659 | Common Stock | |
| Intuitive Surgical | Mohr Marshall L. | Executive VP Global Business S | 28 Feb 2024 | 2,253 | 50,150 (0%) | 0% | 0 | Common Stock | ||
| Intuitive Surgical | L. Mohr Marshall | Executive VP Global Business S | 28 Feb 2024 | 2,253 | 0 | - | - | Restricted Stock Units | ||
| Intuitive Surgical | L. Mohr Marshall | Executive VP Global Business S | 28 Feb 2024 | 1,142 | 49,008 (0%) | 0% | 386.6 | 441,486 | Common Stock | |
| Intuitive Surgical | L. Mohr Marshall | Executive VP Global Business S | 28 Feb 2024 | 1,003 | 2,004 | - | - | Restricted Stock Units | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2024 | 1,003 | 50,011 (0%) | 0% | 0 | Common Stock | ||
| Intuitive Surgical | Marshall Mohr L. | Executive VP Global Business S | 28 Feb 2024 | 509 | 49,502 (0%) | 0% | 386.6 | 196,774 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 26 Feb 2024 | 1,710 | 27,744 (0%) | 0% | 0 | Common Stock | ||
| Intuitive Surgical | Mohr Marshall L. | Executive VP Global Business S | 26 Feb 2024 | 1,710 | 1,710 | - | - | Restricted Stock Units | ||
| Intuitive Surgical | Mohr Marshall L. | Executive VP Global Business S | 26 Feb 2024 | 867 | 26,877 (0%) | 0% | 389.8 | 337,931 | Common Stock | |
| Intuitive Surgical | Marshall Mohr L. | Executive VP Global Business S | 10 Feb 2024 | 2,873 | 2,873 | - | - | Restricted Stock Units | ||
| Intuitive Surgical | Mohr Marshall L. | Executive VP Global Business S | 10 Feb 2024 | 2,873 | 27,119 (0%) | 0% | 0 | Common Stock | ||
| Intuitive Surgical | Mohr L. Marshall | Executive VP Global Business S | 10 Feb 2024 | 1,085 | 26,034 (0%) | 0% | 388.2 | 421,219 | Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 340 | 2,604 (0%) | 0% | 0 | Class A Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 340 | 678 | - | - | Restricted Stock Units | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 339 | 1,018 | - | - | Restricted Stock Units | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 339 | 2,264 (0%) | 0% | 0 | Class A Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 10 Aug 2023 | 2,873 | 2,873 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 1,357 | 1,357 | - | - | Restricted Stock Units | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 14 Jun 2023 | 11,250 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 14 Jun 2023 | 11,250 | 24,136 (0%) | 0% | 325 | 3,656,250 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 14 Jun 2023 | 11,250 | 35,386 (0%) | 0% | 59.5 | 668,950 | Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 366 | 1,925 (0%) | 0% | 0 | Class A Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 366 | 0 | - | - | Restricted Stock Units | |
| Pacific Biosciences of Cal... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 18 May 2023 | 25,000 | 85,000 (0%) | 0% | 2.5 | 63,500 | Common Stock |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 366 | 366 | - | - | Restricted Stock Units | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 366 | 1,559 (0%) | 0% | 0 | Class A Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2023 | 5,746 | 5,746 | - | - | Restricted Stock Units | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2023 | 2,873 | 2,873 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2023 | 2,256 | 24,750 (0%) | 0% | 0 | Common Stock | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2023 | 2,256 | 2,253 | - | - | Restricted Stock Units | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2023 | 1,119 | 23,631 (0%) | 0% | 229.4 | 256,687 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2023 | 1,003 | 3,007 | - | - | Restricted Stock Units | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2023 | 1,003 | 24,634 (0%) | 0% | 0 | Common Stock | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 28 Feb 2023 | 498 | 24,136 (0%) | 0% | 229.4 | 114,236 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 26 Feb 2023 | 1,710 | 3,420 | - | - | Restricted Stock Units | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 26 Feb 2023 | 1,710 | 23,342 (0%) | 0% | 0 | Common Stock | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 26 Feb 2023 | 848 | 22,494 (0%) | 0% | 231.0 | 195,930 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 15 Feb 2023 | 1,749 | 22,500 (0%) | 0% | 0 | Common Stock | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 15 Feb 2023 | 1,749 | 0 | - | - | Restricted Stock Units | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 15 Feb 2023 | 868 | 21,632 (0%) | 0% | 244.8 | 212,460 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 13 Feb 2023 | 54,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 13 Feb 2023 | 54,000 | 54,000 (0%) | 0% | 63.2 | 3,415,262 | Common Stock | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 13 Feb 2023 | 33,249 | 20,751 (0%) | 0% | 245.6 | 8,166,377 | Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 367 | 1,193 (0%) | 0% | 0 | Class A Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 367 | 732 | - | - | Restricted Stock Units | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 366 | 826 (0%) | 0% | 0 | Class A Common Stock | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 366 | 1,099 | - | - | Restricted Stock Units | |
| Intuitive Surgical | Marshall L. Mohr | Executive VP Global Business S | 29 Aug 2022 | 6,015 | 6,015 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Pacific Biosciences of Cal... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.83 per share. | 10 Jun 2022 | 35,000 | 60,000 (0%) | 0% | 1.8 | 64,050 | Common Stock |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 1,465 | 1,465 | - | - | Restricted Stock Units | |
| Veeva Systems Inc - Ordina... | Marshall L. Mohr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 276 | 460 (0%) | 0% | 0 | Class A Common Stock |